Nutrition, Vision, and Cognition in Sport Study: Beef (IONSport:Beef)

June 9, 2020 updated by: Steven E.Riechman, PhD, MPH, Texas A&M University
The purpose of this study is to determine whether a 30 day beef intervention can improve peak cognitive performance in young, normally menstruating adult women. The control group will consume a daily portion of macronutrient equivalent vegetable source of protein.

Study Overview

Detailed Description

The purpose of the Nutrition, Vision, and Cognition in Health Sport: Beef (IONSport-Beef) study is to conduct a randomized controlled trial to evaluate beef as a nutritional intervention to optimize visual cognitive training performance in generally healthy, normally menstruating women. Female subjects of reproductive age (18-40) will be randomly placed in one of two dietary treatment groups: one serving of beef per day for 30 days or a non-meat protein replacement control. Cognitive performance will be measured in 15 training sessions over 10 days using the sophisticated NeuroTracker™ CORE (NT) 3-Dimensional (3D) software program. It is hypothesized that women consuming 1 serving of beef per day for 30 days will have the highest plasma levels of the beef rich nutrients and demonstrate the highest visual cognitive performance and improvement as compared to the no beef control.

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. 18-40 year old female
  2. Eumenorrheic

Exclusion Criteria:

  1. Neuroactive medications such as Ritalin, Adderall, antidepressants etc
  2. Dietary supplements
  3. Iron intake above 15mg/day
  4. Protein intake above 1.5 g/kg/day
  5. More than 1 mild concussion lifetime or 1 mild concussion within the last 12 months
  6. History of affective disorder
  7. Visual impairments uncorrected by glasses
  8. Amenorrhea or dysmenorrhea
  9. Currently being treated for anemia
  10. >3 servings of beef per week
  11. <20 BMI or BMI >35
  12. Consume >100mg caffeine/day (>1 cup of coffee or soda)
  13. <1 hour/week physical activity, >4 hours/week vigorous activity
  14. Depression score >18 (Beck Depression Inventory)
  15. <20 Kcal/kg/day

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 30 day Beef consumption
One serving of beef is consumed each day for 30 days.
Beef patty will replace one of the participants protein servings each day for 30 days. Each serving is 114 grams of 90% lean ground sirloin given to participants as an uncooked frozen patty.
Placebo Comparator: 30 day Veggie Patty consumption
One serving (1 patty) of a vegetable based protein source is consumed each day for 30 days. The weight of the food, total calories, grams of protein, and total fat are the same as the beef serving.
Veggie patty will replace one of the participants protein servings each day for 30 days. No beef will be consumed during this period. The veggie patty is commercially available Morningstar veggie burger and is given to participants in commercial packaging as a frozen precooked patty.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean NeuroTracker Speed Threshold over 300 trials
Time Frame: 15 sessions (300 trials) over 10 days at the end of the nutritional intervention
Cognitive Performance on the Neurotracker 3D software program that includes 20 trials in each session. Particpants will track 4 of 8 balls with increasing speed if successful and slower if unsuccessful.The speed threshold is optimized performance for that session. Across the 15 sessions, mean speed threshold is defined as the average speed threshold for the 15 sessions.
15 sessions (300 trials) over 10 days at the end of the nutritional intervention
Maximal NeuroTracker Speed Threshold over 300 trials
Time Frame: 15 sessions (300 trials) over 10 days at the end of the nutritional intervention
Cognitive Performance on the Neurotracker 3D software program that includes 20 trials in each session. Particpants will track 4 of 8 balls with increasing speed if successful and slower if unsuccessful. The speed threshold is optimized performance for that session. Across the 15 sessions, maximal speed threshold is defined as the highest speed threshold.
15 sessions (300 trials) over 10 days at the end of the nutritional intervention
Change in NeuroTracker Speed Threshold over 300 trials
Time Frame: 15 sessions (300 trials) over 10 days at the end of the nutritional intervention
Cognitive Performance on the Neurotracker 3D software program that includes 20 trials in each session. Particpants will track 4 of 8 balls with increasing speed if successful and slower if unsuccessful. The speed threshold is optimized performance for that session. Across the 15 sessions, change in speed threshold is defined as the difference between the mean of the first three sessions and the mean of the last three sessions.
15 sessions (300 trials) over 10 days at the end of the nutritional intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Markers of anemia
Time Frame: Day 1 and Day 30 of the intervention
blood levels of B12, iron, CBCs, ferritin, hepcidin
Day 1 and Day 30 of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Steve Riechman, PhD, Texas A&M University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2020

Primary Completion (Anticipated)

December 31, 2020

Study Completion (Anticipated)

June 1, 2021

Study Registration Dates

First Submitted

June 6, 2020

First Submitted That Met QC Criteria

June 9, 2020

First Posted (Actual)

June 11, 2020

Study Record Updates

Last Update Posted (Actual)

June 11, 2020

Last Update Submitted That Met QC Criteria

June 9, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Will not share

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Change

Clinical Trials on 30 day Daily consumption of 1 serving of beef

3
Subscribe